Fig. 2From: Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trialOverview of this trial procedure UC-MSCs, umbilical-cord-derived mesenchymal stem cellsBack to article page